Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Pen-sharing poses a risk for transmission of blood-borne pathogens
Role of the funding source There was no funding source for this study
Retatrutide remains strictly an investigational compound studied exclusively within controlled laboratory and clinical research environments
Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis
13(3):e0193473
US$ 28.66
US$ 20.18
US$ 25.41
